DE602005007764D1 - Silanester und silaneamide von 2-oxothiazolidin-4-carbonsäureamide und deren verwendung zur vorbeugung der lichtbedingten hautalterung - Google Patents

Silanester und silaneamide von 2-oxothiazolidin-4-carbonsäureamide und deren verwendung zur vorbeugung der lichtbedingten hautalterung

Info

Publication number
DE602005007764D1
DE602005007764D1 DE602005007764T DE602005007764T DE602005007764D1 DE 602005007764 D1 DE602005007764 D1 DE 602005007764D1 DE 602005007764 T DE602005007764 T DE 602005007764T DE 602005007764 T DE602005007764 T DE 602005007764T DE 602005007764 D1 DE602005007764 D1 DE 602005007764D1
Authority
DE
Germany
Prior art keywords
silanester
silaneamides
oxothiazolidine
skin aging
prevent light
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005007764T
Other languages
German (de)
English (en)
Inventor
Karine Lucet-Levannier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Publication of DE602005007764D1 publication Critical patent/DE602005007764D1/de
Anticipated expiration legal-status Critical
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
DE602005007764T 2004-10-21 2005-09-27 Silanester und silaneamide von 2-oxothiazolidin-4-carbonsäureamide und deren verwendung zur vorbeugung der lichtbedingten hautalterung Active DE602005007764D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0452399A FR2877004B1 (fr) 2004-10-21 2004-10-21 Esters et amides silaniques d'acide 2-oxothiazolidine-4- carboxylique et leurs utilisations cosmetiques.
US63254104P 2004-12-03 2004-12-03
PCT/EP2005/012032 WO2006045639A1 (en) 2004-10-21 2005-09-27 Silane esters and amides of 2-oxothiazolidine-4-carboxylic acid, and cosmetic uses thereof

Publications (1)

Publication Number Publication Date
DE602005007764D1 true DE602005007764D1 (de) 2008-08-07

Family

ID=34950806

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005007764T Active DE602005007764D1 (de) 2004-10-21 2005-09-27 Silanester und silaneamide von 2-oxothiazolidin-4-carbonsäureamide und deren verwendung zur vorbeugung der lichtbedingten hautalterung

Country Status (8)

Country Link
US (1) US7795286B2 (https=)
EP (1) EP1805153B1 (https=)
JP (1) JP5149011B2 (https=)
AT (1) ATE399159T1 (https=)
DE (1) DE602005007764D1 (https=)
ES (1) ES2308565T3 (https=)
FR (1) FR2877004B1 (https=)
WO (1) WO2006045639A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2731298T3 (es) 2005-05-27 2019-11-14 Univ North Carolina Chapel Hill Partículas de liberación de óxido nítrico para agentes terapéuticos de óxido nítrico y aplicaciones biomédicas
EP1968609A4 (en) * 2005-12-20 2010-06-09 Silamed Inc PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE USE OF HIGHLY LIPOPHILIC SULFHYDRYL COMPOUNDS
FR2921257B1 (fr) * 2007-09-21 2009-11-06 Exsymol Sa Utilisation topique de derives thiazolidines contre les consequences du stress oxydatif de la peau
FR2940615B1 (fr) 2008-12-30 2011-12-30 Oreal Association de monosaccharides avec des agents antioxydants et son utilisation en cosmetique
CA2771389C (en) 2009-08-21 2019-04-09 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
WO2011022652A1 (en) 2009-08-21 2011-02-24 Novan, Inc. Topical gels
AU2011227198A1 (en) * 2010-03-17 2012-10-04 Arbonne International Llc Topical skin care composition
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
WO2012118829A2 (en) 2011-02-28 2012-09-07 Novan, Inc. Tertiary s-nitrosothiol-modified nitricoxide-releasing xerogels and methods of using the same
US9132725B2 (en) 2011-05-09 2015-09-15 Cummins Inc. Vehicle and hybrid drive system
US10239847B1 (en) 2016-03-03 2019-03-26 Cellactin Method for 2-oxothiazolidine-4-carboxylic acid for cellular glutathione
JP7118591B2 (ja) 2017-02-28 2022-08-16 ロレアル レゾルシノール又はその誘導体を含む組成物
JP7412898B2 (ja) 2019-04-26 2024-01-15 ロレアル 特異な粒子と親油性抗酸化剤との組み合わせ
JP7612326B2 (ja) 2019-12-16 2025-01-14 ロレアル 特定の成分の組合せを含む安定な組成物
WO2023120259A1 (en) 2021-12-20 2023-06-29 Oreal Stable composition comprising retinoid
FR3131837B1 (fr) 2022-01-19 2024-10-04 Oreal Composition stable comprenant un rétinoïde et un composé acide ascorbique
FR3131845B1 (fr) 2022-01-19 2024-11-01 Oreal Composition stable comprenant un rétinoïde
EP4452190A1 (en) 2021-12-20 2024-10-30 L'oreal Stable composition comprising retinoid and ascorbic acid compound
EP4637675A1 (en) 2022-12-20 2025-10-29 L'oreal Composition comprising hyaluronic acid-based polyion complex and hydrophilic or lipophilic antioxidant
FR3145279B1 (fr) 2023-01-30 2026-01-30 Oreal Composition comprenant un complexe polyionique à base d’acide hyaluronique et un antioxydant lipophile
WO2024135577A1 (en) 2022-12-23 2024-06-27 L'oreal Stable dispersion composition comprising retinoid
FR3145278B1 (fr) 2023-01-30 2026-04-10 Oreal Composition de dispersion stable comprenant un rétinoïde
FR3148912B1 (fr) 2023-05-24 2026-02-20 Oreal Composition comprenant des polymères cationiques et anioniques
FR3152226B3 (fr) 2023-08-25 2025-09-19 Oreal Composition cosmétique anhydre pour une application douce et peu grasse

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208249A (en) * 1992-08-20 1993-05-04 Clintec Nutrition Co. Method for stimulating intracellular synthesis of glutathione using esters of L-2-oxothiazolidine-4-carboxylate
FR2854160B1 (fr) * 2003-04-25 2005-06-17 Oreal Nouveaux derives heterocycliques de l'acide 2-oxothiazolidine4-carboxylique, utilisation comme agent de photoprotection active

Also Published As

Publication number Publication date
ES2308565T3 (es) 2008-12-01
FR2877004A1 (fr) 2006-04-28
US7795286B2 (en) 2010-09-14
EP1805153A1 (en) 2007-07-11
EP1805153B1 (en) 2008-06-25
FR2877004B1 (fr) 2007-03-09
JP5149011B2 (ja) 2013-02-20
ATE399159T1 (de) 2008-07-15
US20090074682A1 (en) 2009-03-19
JP2008517030A (ja) 2008-05-22
WO2006045639A1 (en) 2006-05-04

Similar Documents

Publication Publication Date Title
DE602005007764D1 (de) Silanester und silaneamide von 2-oxothiazolidin-4-carbonsäureamide und deren verwendung zur vorbeugung der lichtbedingten hautalterung
HRP20070203T3 (hr) Derivati n-[fenil(alkilpiperidin-2-il)metil]benzamida, njihovo dobivanje i njihova primjena u terapiji
CO5021127A1 (es) Nuevas dihidropirimidas
UY26695A1 (es) Activadores para amino sustituidos de la fenilamida glucoquinasa
ECSP045369A (es) Derivados de n-[fenil(piperidin-2-il)metil]benzamida, su preparacion y su aplicacion en terapeutica
PE20090606A1 (es) Nuevos inhibidores de catepsina c y uso
PE20080677A1 (es) Inhibidores de pirrolotriazina cinaza
TNSN06419A1 (en) N- (1- (1-benzyl -4-phenyl-1h-imidazol-2-yl) -2,2-dymethylpropyl) benzamide derivatives and related compounds as kinesin spindle protein (ksp) inhibitors for the treatment of cancer
NO20061157L (no) 4-pyramidonderivater og deres anvendelse som peptidylpeptidmeinbibitorer
ECSP034524A (es) Derivados de pirina con actividad inhibidora de quinasa ikb (ikk-beta)
AR044695A1 (es) Derivados de azolidina, utiles como herbicidas.
BRPI0508464B8 (pt) sulfonilpirróis, composição farmacêutica compreendendo os mesmos e uso dos mesmos
BR0116698A (pt) Composto de modafinila e misturas de ciclodextrina, uso e método de obtenção dos mesmos
UY29388A1 (es) Derivados del (1,5-difenil-h-pirazol-3-il)oxadiazol, su preparación y su aplicacion en terapéutica.
NO20063090L (no) Amidopyrazolderivater
HRP20050628A2 (en) Substituted benzoyl derivatives uses as herbicides
TR200301248A2 (tr) Antibiyotik Aktiviteye Sahip Olan Farmasotik Kompozisyonlar.
ATE292281T1 (de) Ionensensitiver feldeffekttransistor und verfahren zum herstellen eines ionensensitiven feldeffekttransistors
CY1110613T1 (el) Υποκατεστημενες θειαζολες και η χρησιμοποιηση τους για την παρασκευη φαρμακων
ECSP078009A (es) Derivados del 4,5-diarilpirrol, su preparación y su aplicación en terapéutica
DOP2009000105A (es) Derivados de pirrol, su preparación y su utilización en terapéutica
DE502004005179D1 (de) Verwendung von Glaszusammensetzungen zum Erzielen eines antioxidativen Effektes
DE60307891D1 (de) Verwendung eines akariziden pulvers
ATE493110T1 (de) Kosmetische zusammensetzung zur stimulierung der synthese der proteine der basalmembran
AR044637A1 (es) Fluorbutenos nematicidas que contienen tiazolina

Legal Events

Date Code Title Description
8364 No opposition during term of opposition